Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Provention Bio stock

Learn how to easily invest in Provention Bio stock.

Provention Bio is a biotechnology business based in the US. Provention Bio shares (PRVB) are listed on the NASDAQ and all prices are listed in US Dollars. Provention Bio employs 82 staff and has a trailing 12-month revenue of around $2.8 million.

How to buy Provention Bio stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – PRVB. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Provention Bio stock price (NASDAQ: PRVB)

Use our graph to track the performance of PRVB stocks over time.

Provention Bio shares at a glance

Information last updated 2023-02-03.
Latest market close$9.10
52-week range$3.19 - $10.88
50-day moving average $9.21
200-day moving average $6.08
Wall St. target price$19.71
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.64

Buy Provention Bio stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Provention Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Provention Bio price performance over time

Historical closes compared with the close of $9.1 from 2023-02-02

1 week (2023-01-27) 3.76%
1 month (2023-01-04) -4.31%
3 months (2022-11-04) 23.31%
6 months (2022-08-04) 112.62%
1 year (2022-02-04) 74.00%
2 years (2021-02-04) -38.64%
3 years (2020-02-04) 14.99
5 years (2018-01-31) N/A

Provention Bio financials

Revenue TTM $2.8 million
Gross profit TTM $-68,232,000
Return on assets TTM -40.46%
Return on equity TTM -76.1%
Profit margin 0%
Book value $1.66
Market capitalisation $793.4 million

TTM: trailing 12 months

Provention Bio share dividends

We're not expecting Provention Bio to pay a dividend over the next 12 months.

Provention Bio share price volatility

Over the last 12 months, Provention Bio's shares have ranged in value from as little as $3.185 up to $10.88. A popular way to gauge a stock's volatility is its "beta".

PRVB.US volatility(beta: 2.29)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Provention Bio's is 2.2885. This would suggest that Provention Bio's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Provention Bio overview

Provention Bio, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co. , Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China.

Frequently asked questions

What percentage of Provention Bio is owned by insiders or institutions?
Currently 6.056% of Provention Bio shares are held by insiders and 46.115% by institutions.
How many people work for Provention Bio?
Latest data suggests 82 work at Provention Bio.
When does the fiscal year end for Provention Bio?
Provention Bio's fiscal year ends in December.
Where is Provention Bio based?
Provention Bio's address is: 55 Broad Street, Red Bank, NJ, United States, 07701
What is Provention Bio's ISIN number?
Provention Bio's international securities identification number is: US74374N1028
What is Provention Bio's CUSIP number?
Provention Bio's Committee on Uniform Securities Identification Procedures number is: 74374N102

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site